1. Home
  2. ARQT vs VSH Comparison

ARQT vs VSH Comparison

Compare ARQT & VSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • VSH
  • Stock Information
  • Founded
  • ARQT 2016
  • VSH 1962
  • Country
  • ARQT United States
  • VSH United States
  • Employees
  • ARQT N/A
  • VSH N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • VSH Electrical Products
  • Sector
  • ARQT Health Care
  • VSH Technology
  • Exchange
  • ARQT Nasdaq
  • VSH Nasdaq
  • Market Cap
  • ARQT 1.6B
  • VSH 1.8B
  • IPO Year
  • ARQT 2020
  • VSH N/A
  • Fundamental
  • Price
  • ARQT $13.52
  • VSH $12.86
  • Analyst Decision
  • ARQT Strong Buy
  • VSH Hold
  • Analyst Count
  • ARQT 6
  • VSH 2
  • Target Price
  • ARQT $18.80
  • VSH $20.50
  • AVG Volume (30 Days)
  • ARQT 2.1M
  • VSH 2.1M
  • Earning Date
  • ARQT 05-06-2025
  • VSH 05-07-2025
  • Dividend Yield
  • ARQT N/A
  • VSH 3.09%
  • EPS Growth
  • ARQT N/A
  • VSH N/A
  • EPS
  • ARQT N/A
  • VSH N/A
  • Revenue
  • ARQT $212,819,000.00
  • VSH $2,906,544,000.00
  • Revenue This Year
  • ARQT $57.99
  • VSH $4.78
  • Revenue Next Year
  • ARQT $41.24
  • VSH $8.38
  • P/E Ratio
  • ARQT N/A
  • VSH N/A
  • Revenue Growth
  • ARQT 100.03
  • VSH N/A
  • 52 Week Low
  • ARQT $6.99
  • VSH $10.35
  • 52 Week High
  • ARQT $17.75
  • VSH $24.69
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 42.59
  • VSH 47.23
  • Support Level
  • ARQT $12.42
  • VSH $12.00
  • Resistance Level
  • ARQT $15.67
  • VSH $13.92
  • Average True Range (ATR)
  • ARQT 0.87
  • VSH 0.57
  • MACD
  • ARQT -0.03
  • VSH 0.23
  • Stochastic Oscillator
  • ARQT 33.69
  • VSH 67.33

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

Share on Social Networks: